GB1219254A - Sydnonimine derivatives - Google Patents

Sydnonimine derivatives

Info

Publication number
GB1219254A
GB1219254A GB05910/69A GB1591069A GB1219254A GB 1219254 A GB1219254 A GB 1219254A GB 05910/69 A GB05910/69 A GB 05910/69A GB 1591069 A GB1591069 A GB 1591069A GB 1219254 A GB1219254 A GB 1219254A
Authority
GB
United Kingdom
Prior art keywords
heterocyclic ring
substituted
cycloalkyl
march
halogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB05910/69A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CH Boehringer Sohn AG and Co KG
Boehringer Ingelheim GmbH
Original Assignee
CH Boehringer Sohn AG and Co KG
Boehringer Ingelheim GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CH Boehringer Sohn AG and Co KG, Boehringer Ingelheim GmbH filed Critical CH Boehringer Sohn AG and Co KG
Publication of GB1219254A publication Critical patent/GB1219254A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/04—1,2,3-Oxadiazoles; Hydrogenated 1,2,3-oxadiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
GB05910/69A 1968-03-26 1969-03-26 Sydnonimine derivatives Expired GB1219254A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19681770061 DE1770061A1 (de) 1968-03-26 1968-03-26 Neue substituierte 3-Amino-4-bromsydnomimine

Publications (1)

Publication Number Publication Date
GB1219254A true GB1219254A (en) 1971-01-13

Family

ID=5700383

Family Applications (1)

Application Number Title Priority Date Filing Date
GB05910/69A Expired GB1219254A (en) 1968-03-26 1969-03-26 Sydnonimine derivatives

Country Status (18)

Country Link
AT (1) AT285619B (pt)
BE (1) BE730510A (pt)
BG (1) BG15220A3 (pt)
BR (1) BR6907417D0 (pt)
CA (1) CA945990A (pt)
CH (1) CH519511A (pt)
DE (1) DE1770061A1 (pt)
DK (1) DK130296B (pt)
ES (2) ES364979A1 (pt)
FI (1) FI54480C (pt)
FR (1) FR2004770A1 (pt)
GB (1) GB1219254A (pt)
HU (1) HU162735B (pt)
IE (1) IE32708B1 (pt)
IL (1) IL31909A (pt)
NL (1) NL6904632A (pt)
SE (1) SE374746B (pt)
YU (1) YU69369A (pt)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4305939A (en) 1979-07-28 1981-12-15 Cassella Ag 3-Aminosydnonimines, their preparation and use

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4305939A (en) 1979-07-28 1981-12-15 Cassella Ag 3-Aminosydnonimines, their preparation and use
US4332801A (en) 1979-07-28 1982-06-01 Cassella Aktiengesellschaft 3-Aminosydnonimines, their preparation and use

Also Published As

Publication number Publication date
HU162735B (pt) 1973-04-28
NL6904632A (pt) 1969-09-30
AT285619B (de) 1970-11-10
DK130296B (da) 1975-02-03
ES364979A1 (es) 1971-02-16
IE32708L (en) 1969-09-26
ES376981A1 (es) 1972-05-01
BG15220A3 (bg) 1975-11-21
IL31909A0 (en) 1969-05-28
FI54480B (fi) 1978-08-31
IE32708B1 (en) 1973-10-31
BE730510A (pt) 1969-09-26
FR2004770A1 (pt) 1969-11-28
CH519511A (de) 1972-02-29
YU69369A (en) 1978-09-18
BR6907417D0 (pt) 1973-04-12
IL31909A (en) 1973-01-30
FI54480C (fi) 1978-12-11
DE1770061A1 (de) 1971-09-16
SE374746B (pt) 1975-03-17
DK130296C (pt) 1975-06-30
CA945990A (en) 1974-04-23

Similar Documents

Publication Publication Date Title
GB1409693A (en) Triazolobenzodiazepines
GB1432576A (en) Substituted phenylacetic acids
GB1418822A (en) Imidazo-and pyrimido-2,1-b-quinazolin-2-ones and a process for the preparation thereof
IE43312L (en) Propanolamine derivatives
GB1147379A (en) 4-alkyl-dialkoxy-ª‡-methylphenethylamines and pharmacologically acceptable salts
ES368973A1 (es) Procedimiento de preparacion de nuevos derivados del cina- moil-5 benzofurano.
GB1456627A (en) Pyridobenzodiazepinones
GB1297386A (pt)
GB1367785A (en) 2-substituted adenosine derivatives and the production thereof
GB1394568A (en) Diazepine derivatives and process for the production thereof
GB1434805A (en) 5-phenoxy-4-amino pyrimidines
GB1443692A (en) 1,2-diphenylethanolamine derivatives and their salts and the preparation thereof
GB1219254A (en) Sydnonimine derivatives
GB1292410A (en) Thienobenzothiazepine derivatives
GB1206088A (en) New pyrazolodiazepinone compounds and methods for their production
GB1462095A (en) Substituted triazolo-1,5-benzodiazepines
GB1290381A (pt)
GB1449078A (en) Phenoxyethylamine derivatives
GB1449426A (en) Phenoxyalkylamine derivatives and preparation therof
GB1345214A (en) Isoxazoles
GB1369580A (en) Tricyclic diphenylamine derivatives
GB1433103A (en) Pharmacologically active pyrrolodiazepines
GB1338459A (en) Flavanone derivatives and process for inhibiting growth of microorganisms using such compounds
GB1254270A (en) Benzoxazepine derivatives
GB1468079A (en) Ethanolamine derivatives